[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Thanos D. Halazonetis<\/i><\/u><\/presenter>. University of Geneva, Geneva, Switzerland","CSlideId":"","ControlKey":"4bc26f1f-e198-4246-add4-0fe6c056acdd","ControlNumber":"9427","DisclosureBlock":"&nbsp;<b>&nbsp;T.D. Halazonetis:<\/b>  ; FoRx Therapeutics.","End":"4\/6\/2024 2:31:00 PM","HasWebcast":null,"Highlights":[],"Id":"1043","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Thanos Halazonetis, DDS;PhD","PresenterKey":"1d8ad735-558f-4b34-bf5c-7ab1e0623c42","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chairperson","SearchResultFooter":"","SearchResultHeader":"Apr  6 2024  2:30PM","SessionId":"486","SessionOnDemand":"False","SessionTitle":"New Targets and Mechanisms of Synthetic Lethality in Cancer Therapy","ShowChatLink":"false","Start":"4\/6\/2024 2:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Thanos D. Halazonetis<\/i><\/u><\/presenter>. University of Geneva, Geneva, Switzerland","CSlideId":"","ControlKey":"372ba51e-8a94-419f-a659-928b0fbab015","ControlNumber":"9614","DisclosureBlock":"<b>&nbsp;T. D. Halazonetis, <\/b> <br><b>FoRx Therapeutics<\/b> S.","End":"4\/6\/2024 2:31:00 PM","HasWebcast":null,"Highlights":[],"Id":"2985","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Thanos Halazonetis, DDS;PhD","PresenterKey":"1d8ad735-558f-4b34-bf5c-7ab1e0623c42","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chair Introduction","SearchResultFooter":"","SearchResultHeader":"Apr  6 2024  2:30PM","SessionId":"486","SessionOnDemand":"False","SessionTitle":"New Targets and Mechanisms of Synthetic Lethality in Cancer Therapy","ShowChatLink":"false","Start":"4\/6\/2024 2:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chair Introduction","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Thanos D. Halazonetis<\/i><\/u><\/presenter>. University of Geneva, Geneva, Switzerland","CSlideId":"","ControlKey":"ab3f0563-ee42-41cb-877d-552d4f8a48ca","ControlNumber":"9615","DisclosureBlock":"<b>&nbsp;T. D. Halazonetis, <\/b> <br><b>FoRx Therapeutics<\/b> S.","End":"4\/6\/2024 2:51:00 PM","HasWebcast":null,"Highlights":[],"Id":"2986","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Thanos Halazonetis, DDS;PhD","PresenterKey":"1d8ad735-558f-4b34-bf5c-7ab1e0623c42","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"PARP trapping is dispensable for the synthetic lethality of PARP inhibitors with homologous recombination deficiencies","SearchResultFooter":"","SearchResultHeader":"Apr  6 2024  2:30PM","SessionId":"486","SessionOnDemand":"False","SessionTitle":"New Targets and Mechanisms of Synthetic Lethality in Cancer Therapy","ShowChatLink":"false","Start":"4\/6\/2024 2:31:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"PARP trapping is dispensable for the synthetic lethality of PARP inhibitors with homologous recombination deficiencies","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"c804ecd9-2ea0-471a-9991-ed4016777744","ControlNumber":"10973","DisclosureBlock":"","End":"4\/6\/2024 3:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"8866","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  6 2024  2:30PM","SessionId":"486","SessionOnDemand":"False","SessionTitle":"New Targets and Mechanisms of Synthetic Lethality in Cancer Therapy","ShowChatLink":"false","Start":"4\/6\/2024 2:51:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Jasgit C. Sachdev<\/i><\/u><\/presenter>. IDEAYA Biosciences, San Diego, CA","CSlideId":"","ControlKey":"ec3e5550-c2d6-4187-b28f-809202a251ff","ControlNumber":"9616","DisclosureBlock":"","End":"4\/6\/2024 3:20:00 PM","HasWebcast":null,"Highlights":[],"Id":"2987","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Jasgit Sachdev","PresenterKey":"206122f0-2a61-4de1-9db5-865e2870d4ee","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"PARG inhibitors, a new class of agents exploiting synthetic lethality in cancer","SearchResultFooter":"","SearchResultHeader":"Apr  6 2024  2:30PM","SessionId":"486","SessionOnDemand":"False","SessionTitle":"New Targets and Mechanisms of Synthetic Lethality in Cancer Therapy","ShowChatLink":"false","Start":"4\/6\/2024 3:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"PARG inhibitors, a new class of agents exploiting synthetic lethality in cancer","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"6af21697-a508-4194-a26b-58753b31b83e","ControlNumber":"10974","DisclosureBlock":"","End":"4\/6\/2024 3:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"8867","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  6 2024  2:30PM","SessionId":"486","SessionOnDemand":"False","SessionTitle":"New Targets and Mechanisms of Synthetic Lethality in Cancer Therapy","ShowChatLink":"false","Start":"4\/6\/2024 3:20:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Zev A. Wainberg<\/i><\/u><\/presenter>. UCLA Medical Center Santa Monica, Santa Monica, CA","CSlideId":"","ControlKey":"ea2aec2e-244b-455c-b9ad-66aba3b39e78","ControlNumber":"9617","DisclosureBlock":"<b>&nbsp;Z. A. Wainberg, <\/b> <br><b>Amgen<\/b> I. <br><b>AngioDynamics, Inc.<\/b> I. <br><b>Astellas Pharma<\/b> I. <br><b>AstraZeneca<\/b> I. <br><b>Bristol-Myers Squibb<\/b> I. <br><b>Daiichi Sankyo Company<\/b> I. <br><b>Eli LIlly<\/b> I. <br><b>Ipsen Biopharmaceuticals, Inc<\/b> I. <br><b>Merck<\/b> I. <br><b>Novartis<\/b> I.","End":"4\/6\/2024 3:50:00 PM","HasWebcast":null,"Highlights":[],"Id":"2988","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Zev Wainberg, MD","PresenterKey":"6aeb6215-8fc3-43e0-b38e-e1ffb5ff1c89","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Mechanisms and clinical study design to examine the synthetic lethality of WRN inhibitors with mismatch repair deficiency","SearchResultFooter":"","SearchResultHeader":"Apr  6 2024  2:30PM","SessionId":"486","SessionOnDemand":"False","SessionTitle":"New Targets and Mechanisms of Synthetic Lethality in Cancer Therapy","ShowChatLink":"false","Start":"4\/6\/2024 3:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Mechanisms and clinical study design to examine the synthetic lethality of WRN inhibitors with mismatch repair deficiency","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"fcb8b7df-a3d9-4b8d-872b-2aa7f9cd5342","ControlNumber":"10975","DisclosureBlock":"","End":"4\/6\/2024 4:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"8868","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"8","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  6 2024  2:30PM","SessionId":"486","SessionOnDemand":"False","SessionTitle":"New Targets and Mechanisms of Synthetic Lethality in Cancer Therapy","ShowChatLink":"false","Start":"4\/6\/2024 3:50:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""}]